Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 17.52x is 29% below its 5-year average of 24.81x, around the middle of its 5-year range (-145.05x–110.44x).
17.31% below its 12-month average of 21.19x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 20.40x.
INTEREST COVERAGE RATIO
17.52x
INTEREST COVERAGE RATIO AVG TTM
21.19x
INTEREST COVERAGE RATIO AVG 3Y
19.98x
INTEREST COVERAGE RATIO AVG 5Y
24.81x
INTEREST COVERAGE RATIO AVG 10Y
27.98x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-17.31%
CURRENT VS 3Y AVG
-12.30%
CURRENT VS 5Y AVG
-29.37%
CURRENT VS 10Y AVG
-37.39%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+374.82%
vs the sector median at left
Viemed Healthcare, Inc.
Market Cap
$355.36M
Interest Coverage Ratio
17.52x
TTM Avg
21.19x
3Y Avg
19.98x
5Y Avg
24.81x
Market Cap
$355.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$353.88M
Interest Coverage Ratio
-11.11x
TTM Avg
316.78x
3Y Avg
4209.35x
5Y Avg
3030.57x
Market Cap
$353.00M
Interest Coverage Ratio
3.07x
TTM Avg
2.31x
3Y Avg
3.74x
5Y Avg
3.74x
Market Cap
$352.67M
Interest Coverage Ratio
-12.13x
TTM Avg
372.18x
3Y Avg
320.22x
5Y Avg
320.22x
Market Cap
$359.53M
Interest Coverage Ratio
-3.05x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
Market Cap
$349.70M
Interest Coverage Ratio
-45.13x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$361.64M
Interest Coverage Ratio
-26.33x
TTM Avg
2025.11x
3Y Avg
2025.11x
5Y Avg
2025.11x
Market Cap
$346.73M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viemed Healthcare, Inc. (VMD) | $355.36M | 17.52x | 21.19x | 19.98x | 24.81x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | N/A | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.88M | -11.11x | 316.78x | 4209.35x | 3030.57x |
| Embecta Corp. (EMBC)vs › | $353.00M | 3.07x | 2.31x | 3.74x | 3.74x |
| Ocugen, Inc. (OCGN)vs › | $352.67M | -12.13x | 372.18x | 320.22x | 320.22x |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | -3.05x | 0.61x | 0.61x | 0.61x |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | -45.13x | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | -26.33x | 2025.11x | 2025.11x | 2025.11x |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | N/A | N/A | N/A | N/A |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | N/A | N/A | N/A | N/A |
Interest Coverage
17.5x
Debt/Equity
0.08
Current Ratio
1.13
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 20.40x |
| 2026-03-31 | 15.50x |
| 2025-12-31 | 23.79x |
| 2025-09-30 | 12.07x |
| 2025-06-30 | 34.18x |
| 2025-03-31 | 21.46x |
| 2024-12-31 | 43.89x |
| 2024-09-30 | 25.01x |
| 2024-06-30 | 14.24x |
| 2024-03-31 | 14.69x |
| 2023-12-31 | 20.66x |
| 2023-09-30 | 17.75x |
| 2023-06-30 | -145.05x |
| 2022-12-31 | 110.44x |
| 2022-09-30 | 34.98x |
| 2022-06-30 | 16.97x |
| 2022-03-31 | 35.13x |
| 2021-12-31 | 67.61x |
| 2021-09-30 | 38.92x |
| 2021-06-30 | 32.10x |
| 2021-03-31 | 14.64x |
| 2020-12-31 | 52.67x |
| 2020-09-30 | 34.83x |
| 2020-06-30 | 95.25x |
| 2020-03-31 | 29.21x |
| 2019-12-31 | 12.70x |
| 2019-09-30 | 39.04x |
| 2019-06-30 | 83.20x |
| 2019-03-31 | 89.04x |
| 2018-12-31 | 25.20x |
| 2018-09-30 | 73.41x |
| 2018-06-30 | 38.15x |
| 2018-03-31 | 85.70x |
| 2017-12-31 | 36.08x |
| 2017-09-30 | 78.40x |
| 2017-06-30 | 38.89x |
| 2017-03-31 | -17.96x |
| 2016-12-31 | 25.74x |
| 2016-09-30 | 3.56x |
